Elizabeth Cunningham

Elizabeth Cunningham is a seasoned clinical research professional with extensive experience in oncology and gene therapy. Currently serving as Senior Director and Clinical Research Scientist at Incyte since January 2023, Cunningham supports multiple Phase 1-3 trials in immuno-oncology and targeted therapeutics. Previously, as Senior Director of Clinical Operations at Passage Bio, the focus was on the GM1 pediatric program in CNS gene therapy. Earlier roles at GSK included Clinical Scientist for global BLENREP studies in multiple myeloma and Senior Clinical Development Manager overseeing multiple Phase I-II studies. Cunningham's career further includes significant positions at Merck and GSK, with contributions in melanoma and stroke research, along with volunteering in STEM education. Elizabeth holds a Master's degree in Clinical Microbiology from Jefferson Health and a Bachelor's degree in Biology from Marymount College.